Pharmacogenetic differences and drug–drug interactions in immunosuppressive therapy

Author： Warrington Jill S   Shaw Leslie M  

Publisher： Informa Healthcare

ISSN： 1742-5255

Source： Expert Opinion on Drug Metabolism and Toxicology, Vol.1, Iss.3, 2005-10, pp. : 487-503

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pharmacogenetic Variation in Drug Oxidizing CYPs: Impact on Drug Therapy, Drug Safety and Drug Interactions

By  

Current Pharmacogenomics, Vol. 1, Iss. 3, 2003-09 ,pp. : 159-173

Bentham Science Publishers

Access to resources Recommend Favorite

Hepatic OATP and OCT uptake transporters: their role for drug-drug interactions and pharmacogenetic aspects

By Fahrmayr Christina   Fromm Martin F.   König Jörg  

Drug Metabolism Reviews, Vol. 42, Iss. 3, 2010-08 ,pp. : 380-401

Informa Healthcare

Access to resources Recommend Favorite

Drug–drug interactions and tolerance in combining antituberculosis and antiretroviral therapy

By Di Perri Giovanni   Aguilar Marucco Diego   Mondo Alessandra   Gonzalez de Requena Daniel   Audagnotto Sabrina   Gobbi Federico   Bonora Stefano  

Expert Opinion on Drug Safety, Vol. 4, Iss. 5, 2005-09 ,pp. : 821-836

Informa Healthcare

Access to resources Recommend Favorite

Maraviroc potential drug-drug interactions

By  

Reactions Weekly, Vol. 1, Iss. 1207, 2008-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite

Transporter-mediated drug––drug interactions

By Müüller Fabian   Fromm Martin F  

Pharmacogenomics, Vol. 12, Iss. 7, 2011-07 ,pp. : 1017-1037

Future Medicine

Access to resources Recommend Favorite